期刊文献+

1,25-二羟维生素D_3对糖尿病大鼠肺脏的保护作用及机制 被引量:1

Protective effect of 1,25-dihydroxyvitamin D_3 on lung tissues of diabetic rats
下载PDF
导出
摘要 目的观察1,25-二羟维生素D3[1,25-(OH)2D3]对糖尿病大鼠炎性水平及肺组织Toll样受体4(TLR4)表达的影响,探讨其肺保护作用及机制。方法将90只SD大鼠随机分为对照组(C组)10只及模型组80只,模型组经尾静脉注射STZ制备糖尿病模型,C组注射等体积柠檬酸缓冲液;将模型组造模成功的75只大鼠随机分为糖尿病组(D组),1,25-(OH)2D3大、中、小剂量干预组(H、M、L组)及精蛋白锌胰岛素干预组(Y组)各15只,其中H、M、L组分别予0.3、0.15、0.025μg/(kg·d)的1,25-(OH)2D3灌胃,Y组予胰岛素颈后皮下注射,C组和D组予蒸馏水2 mL灌胃,均为1次/d、连续16周,16周后所有动物均采用股动脉放血处死,立即取肺脏组织置于10%甲醛及液氮中保存。测定各组血糖及血清CRP水平;采用HE、Masson染色法观察肺组织形态学变化,免疫组织化学法检测TLR4、NF-κB p65的蛋白表达;采用PCR法定量检测TLR4、MyD88、NF-κB p65的mRNA表达。结果①D组血糖及血清CRP水平均显著高于C组(P<0.01),各干预组均不同程度低于D组,尤以H组为著(P<0.01)。②D组肺泡壁重度增厚、肺间质明显增生、大量炎症细胞浸润,H、Y、M及L组肺泡壁轻到中度增厚、炎细胞浸润明显;与C组比较,余5组TLR4、NF-κB p65蛋白表达有所升高,其中H、Y组显著低于D组。③D组TLR4、MyD88和NF-κB p65的mRNA表达显著高于C组(P<0.01),各干预组表达水均低于D组。肺组织TLR4 mRNA表达与MyD88 mRNA(r=0.610)、NF-κB p65 mRNA表达(r=0.744)均呈正相关,P均<0.001;MyD88 mRNA与NF-κB p65mRNA表达亦呈正相关(r=0.609),P<0.001。结论 1,25-(OH)2D3可能通过TLR4介导的炎症途径对STZ诱导的糖尿病大鼠肺脏病变发挥保护作用。 Objective % observe the effect of I, 25-dihydroxyvitamin D3(1, 25-(OH)2D3) on inflammatory level and Toll-like receptor 4 (TLR4) expression of lung tissues in diabetic rats, and to investigate the mechanism of the lung protective effect. Methods Ninety SD rats were randomly divided into the control group (group C, n = 10) and diabetic model group (n =80). Streptozotocin (STZ) was injected into caudal veins to generate diabetic models, with 75 diabetic rats generated. Cit rate buffer was injected into group C. Seventy-five diabetic rats were randomly divided into five groups (n =15), including dia betic group (group D), high-dose (group H), medium-dose (group M) and low-dose 1,25-(OH)2D3 intervention groups (group L) and pretamine zinc insulin group (group Y). Rats in group H, M and L were administered 0.3 μg/(kg . d), 0. 15μG/ (kg- d), 0.025 pg/(kg . d)1,25-(OH)2D3 intragastrieally respectively. Group Y was given 16 U/(kg^-1 . d) insulin hypoder mic injection in posterior of the neck. Group D and C were given distilled water intragastrically. All rats were sacrificed after 16 weeks by femoral artery hemorrhage. Lung samples were placed in 10% neutral formalin and liquid nitrogen. Blood glucose and serum CRP levels were determined. PAthological alterations in lung tissues were observed through HE and Masson stain. The pro tein expression of TLR4 and NF-r,B p65 was detected by immunohistochemistry. The expression of TLR4, MyD88 and NF-KB 1365 mRNA was quantitatively measured by PCR. Results 1. Blood glucose and serum CRP levels were significantly higher in groupD than those in group C (P 〈 0. 01 ), and lower in all intervention groups, especially in group H (P 〈 0. 01 ). 2. Group D showed severe alveolar wall thickening, significant interstitial proliferation and massive inflammatory cell infiltration. Group H, Y, M and L showed mild to moderate alveolar wall thickening and inflammatory cell infiltration. TLR4 and NF-KB p65 protein expression was significantly higher in all 5 diabetic model groups than that in group C, and significantly lower in group H and Y as compared with that of group D. 3. The expression levels of TLR4, MyD88, and NF-KB 1365 mRNA were significantly higher in group D than those in group C (P 〈 0. O1 ), and lower in all intervention groups as compared with that in group D. TLR4 mRNA expression was positively correlated with both MyD88 ( r = 0. 610, P 〈 0. 001 ) and NF-KB p65 ( r = 0. 744, P 〈 0.001 ) mRNA ex- pression. MyD88 and NF-KB p65 mRNA expression was also positively correlated (r =0. 609, all P 〈0. 001 ). Cotwdusion 1, 25-(OH)2D3 may exert lung protective effect in STZ-induced diabetic rats by down-regulating TLR4-mediated inflammatory path- way.
出处 《山东医药》 CAS 2013年第47期11-14,共4页 Shandong Medical Journal
基金 天津市卫生局科技基金资助项目(2011KZ112)
关键词 糖尿病 炎症 TOLL样受体4 1 25-二羟维生素D3 diabetes mellitus lung inflammation Toll-like receptor 4 1, 25-dihydroxyvitamin D3
  • 相关文献

参考文献13

  • 1Kaur H,Chien A,Jialal I.Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesanglal cells:relevance to diabetic nephropathy[J] .Am J Physiol Renal Physiol,2012,303(8):1145-1150.
  • 2Buraczynska M,Baranowicz-Gaszczyk I,Tarach J,et al.Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes[J] .Hum Immunol,2009,70(2):121-124.
  • 3Rudofsky G Jr,Reismann P,Witte S,et al.Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes[J] .Diabetes Care,2004,27 (1):179-183.
  • 4Hodgkinson CP,Laxton RC,Patel K,et al.Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis[J] .Arterioscler Thromb Vasc Biol,2008,28 (12):2275-2281.
  • 5Du T,Zhou ZG,You S,et al.Regulation by 1,25-dihydrexy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes[J] .Clin Chim Acta,2009,402(1-2):133-138.
  • 6Barton GM,Kagan JC.A cell biological view of Toll-like receptor function:regulation through compartmentalization[J] .Nat Rev Immunol,2009,9(8):535.
  • 7Arancibia SA,Beltrán C J,Aguirre IM,et al.Toll-like receptors are key participants in innate immune responses[J] .Biol Res,2007,40(2):97.
  • 8Devaraj S,Dasu MR,Rockwood J,et al.Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes:further evidence of a proinflammatory state[J] .J Clin Endocrinol Metab,2008,93(2):578-583.
  • 9张放,李铁英,康健.TLR4在糖尿病大鼠肺组织表达的变化及对脂多糖反应性的研究[J].山东医药,2009,49(12):28-29. 被引量:4
  • 10Cetinkalp S,Delen Y,Karadeniz M,et al.The effect of 1 alpha,25 (OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where Type 1 diabetes is formed by streptozotocin[J] .J Diabetes Complications,2009,23 (6):401-408.

二级参考文献13

  • 1Devaraj S, Dasu MR, Rockwood J, et al. Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state [ J ]. J Clin Endocrinol Metab, 2008,93(2) :578-583.
  • 2Pasare C, Medzhitov R. Toll-like receptors: linking innate and a- daptive immunity [J]. Adv Exp Med Biol, 2005,560:11-18.
  • 3Suthagar E, Soudamani S, Yuvaraj S, et al. Effects of streptozotocin (STZ) -induced diabetes and insulin replacement on rat ventral prostate [J]. Biomed Pharmacother, 2009,63( 1 ) :43-50.
  • 4Tillema MS, Lorenz KL, Weiss MG, et al. Sublethal endotoxemia promotes pulmonary cytokine-induced neutrophil chemoattractant expression and neutrophil recruiment but not overt lung injury in neonatal rats [J]. Biol Neonate, 2000,78(4):308-314.
  • 5Zipris D, Lien E, Nair A, et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat [ J ]. J Immunol, 2007, 178 ( 2 ) : 693-701.
  • 6Fasciano S, Li L. Intervention of Toll-like receptor-mediated human innate immunity and inflammation by synthetic compounds and naturally occurring products [ J ]. Curr Med Chem, 2006, 13 ( 12 ) : 1389-1395.
  • 7Alyanakian MA, Grela F, Aumeunier A, et al. Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes [ J ]. Diabetes, 2006, 55( 1 ) :179-185.
  • 8Vabulas RM, humad-Nejad P, dalosta C, et al. Endocytosed HSP 60s use Toll-like receptor 2 and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate cells [ J ]. Biol Chem, 2001,276(33) :331-332.
  • 9Mohammad MK, Morran M, Leaman DW. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse [J]. Int Immunol, 2006,18(7) :1101-1113.
  • 10Friedman AN, Hunsicker LG, Selhub J, et al. C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy[J]. Kidney Int, 2005,68(2) :773-778.

共引文献18

同被引文献26

  • 1赵素娥,彭毅强.浅谈维生素D与慢性阻塞性肺疾病的关系及最新研究进展[J].当代医药论丛,2014,12(6):149-151. 被引量:2
  • 2Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 2$-hydroxyvitamin D[ J]. Curt Opin Endocrinol Di- abetes Obes ,2008,15 ( 6 ) :489-494.
  • 3Looker AC, Pfeiffer CM, Lacher D, et al. Serum 25-Hydroxyvitamin D status of the US populatjon : 1988-1994 compared wi [ S ] , 2008 : 1519- 1527.
  • 4Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treat- ment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline [ J]. J Clin Endocrinol Metab, 2011,96 (7) : 1911-1930.
  • 5Arnson Y,Gringauz I,Itzhaky D,et al. Vitamin D deficiency is associat- ed with poor outcomes and increased mortality in severely ill patients [ J ]. QJM-An Inter J Med,2012,105 (7) :633-639.
  • 6Ito I, Waku T. Anonclassical vitamin D receptor pathway suppresses re- nal fibrosis [ J]. Clin Invest ,2013,123 ( 11 ) :4579-4594.
  • 7Ramirez AM, Wongtrakool C, Welch T, et al. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor betal in lung fibroblasts and epithelial cells [ J 1. J Steroid Biochem Mol Biol, 2010,118 ( 3 ) : 142-150.
  • 8Nguyen TM, Guillozo H, Matin L, et al. 1,25-dihydroxyvitamin D3 re- ceptors in rat lung during the perlnatal period:regulation and immuno- histochemical localiza-tion [ J ]. Endocrinology, 1990, 127 (4) : 1755- 1762.
  • 9Menezes RJ,Cheney RT,Husain A, et al. Vitamin D receptor epressionin normal, premalignant, and malignant human lung tissue [ J ]. Cancer Epidemiol Biomarkers Prey,2008,17 (5) : 1104-1110.
  • 10Phokela SS, Peleg S, Moya FR, et al. Regulation of human pulmonary surfactant protein gene expression by 1 c~, 25-dihydroxyvitamin D3 [ J 1. Am J Physiol Lung Cell Mol Physio1,2005,289 (4) : L617-L626.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部